Angiomax

Active Ingredient(s): Bivalirudin
FDA Approved: * December 15, 2000
Pharm Company: * MEDICINES CO
Category: Blood Thinner (Anticoagulant)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Angiomax Overview

Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a direct thrombin inhibitor (DTI).[1] Chemically, it is a synthetic congener of the naturally occurring drug hirudin (found in the saliva of the medicinal leech Hirudo medicinalis). Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide. It is a potent and highly specific inhibitor of thrombin.[1&...

Read more Angiomax Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bivalirudin

Recent Angiomax Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bivalirudin
  • Injection: 250mg, 250mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Angiomax: (2 results)

Sorted by National Drug Code
  • 55154-2275 Angiomax 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Cardinal Health
  • 65293-001 Angiomax 250 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by The Medicines Company

Other drugs which contain Bivalirudin or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA